Fagron | Sustainability Performance
Fagron NV specializes in pharmaceutical products and compounding services. The company aims to provide tailored medications that meet specific patient needs while maintaining compliance with regulatory standards.
1990
Belgium
1,001 - 5,000 employees
Pharmaceuticals
$1B - 10B in revenue
$100M - 500M in profitability
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#3585
Overallⓘ#47
in Belgiumⓘ#85
in PharmaceuticalsⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Environmental
Energy consumptionGovernance
TargetsFinancial Data
Business performanceCapital & innovationAnalyst projections
Laggard
Controversy level
- Fagron NV, Belgianlisted major compounding pharmacy (pharmacy compounding ingredients), has faced multiple US class actions over alleged inadequate disclosure of US/European compounding pharmacy customer demand normalization following the contested 2024 sustained share price volatility amid postCOVID GLP1 (Ozempic/Wegovy) compounding pharmacy customer demand normalization affecting Belgian institutional shareholders amid US compounding pharmacy regulatory pressure (FDA crackdown).
Sustainability employees
ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.Total sustainability employees
2-3
ⓘThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.